Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/9314042

Eur. J. Pharmacol. 1997 Aug 27 333 2-3 249-59

Download in:

View as

General Info

PMID
9314042